Kristi McIntyre, M.D. | Texas Oncology

Dr. Kristi McIntyre, MD

Claim this profile

Texas Oncology - Dallas Presbyterian Hospital

Expert in Cancer
Studies Breast Cancer
26 reported clinical trials
52 drugs studied

About Kristi McIntyre, MD

Education:

  • Obtained MD from the University of Texas Southwestern Medical Center in 2009.
  • Completed Residency in Internal Medicine at the University of Texas Southwestern Medical Center in 2012.
  • Finished Fellowship in Hematology/Oncology at the University of Texas Southwestern Medical Center in 2015.

Experience:

  • Practicing as a medical oncologist and hematologist at Texas Oncology - Dallas Presbyterian Hospital since 2015.

Area of expertise

1

Cancer

Global Leader

Kristi McIntyre, MD has run 12 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
BRCA positive
2

Breast Cancer

Kristi McIntyre, MD has run 10 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
Stage III
HER2 negative

Affiliated Hospitals

Image of trial facility.

Texas Oncology - Dallas Presbyterian Hospital

Image of trial facility.

Texas Oncology Presbyterian Cancer Center Dallas

Clinical Trials Kristi McIntyre, MD is currently running

More about Kristi McIntyre, MD

Clinical Trial Related

13 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Kristi McIntyre, MD has experience with

  • Gemcitabine
  • Dexamethasone
  • Mirvetuximab Soravtansine
  • Rituximab
  • Imlunestrant
  • Abemaciclib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Kristi McIntyre, MD specialize in?

Is Kristi McIntyre, MD currently recruiting for clinical trials?

Are there any treatments that Kristi McIntyre, MD has studied deeply?

What is the best way to schedule an appointment with Kristi McIntyre, MD?

What is the office address of Kristi McIntyre, MD?

Is there any support for travel costs?